Shareholders of Ontario-based cannabis producer Emblem approved a 173 million Canadian dollar ($128 million) buyout from vertically integrated company Aleafia Health in a deal that puts the two companies at the forefront of a wave of consolidation in the marijuana industry.
Matt Lamers
Matt Lamers's Latest Posts
Canopy recalls some adult-use cannabis in Canada
A voluntary recall has been issued for some of Canopy Growth’s whole flower cannabis brand “LBS Sunset” sold throughout Canada between Feb. 7 and Feb. 27.
Aphria’s flagship CA$190 million cannabis greenhouse is fully licensed
Aphria’s primary cannabis facility in Leamington, Ontario, is now fully authorized by Health Canada to begin cultivation, paving the way for the first products from the licensed producer’s massive expansion to reach consumers as early as this summer.
Embattled Canadian marijuana firm Ascent receives creditor protection
Canadian cannabis company Ascent Industries has been granted creditor protection by the Supreme Court of British Columbia to address liquidity issues, caused “in large part” by the suspension of its licenses.
Ontario marijuana company CannTrust seeks authorization to raise up to CA$700 million
Ontario-based cannabis producer CannTrust Holdings has laid the groundwork to raise up to $700 million Canadian dollars ($525 million) by filing a base level prospectus with Canadian securities agencies and the U.S. Securities and Exchange Commission.
Illicit cannabis sales in Canada decline after legalization
Early sales of regulated adult-use cannabis chipped away at the illicit market in the final quarter of last year – the first period of legal recreational cannabis sales – with black market purchases declining 8% in the October-December period, according to fresh data from Statistics Canada.
Mold, labeling errors cause rash of cannabis recalls in Canada
A number of cannabis recalls over labeling errors and mold is a sign that the federal health department’s regulatory oversight is working, an industry representative said. Seven notices involving cannabis have been posted to Health Canada’s recall portal since Oct....
Good Manufacturing Practice certification is key for medical marijuana companies with global ambitions
Good Manufacturing Practice certification is generally a prerequisite to the export of medical cannabis. But it’s a long, costly process.
Switzerland to embark on economic, social study of adult-use cannabis
Switzerland has proposed a pilot project to study the economic and health impacts of nonmedical cannabis use, but any change in the country’s laws to create a sustainable adult-use cannabis industry could be years away.
Canopy enlists celebrity Martha Stewart as CBD ‘adviser’
Canopy Growth has lined up celebrity lifestyle guru Martha Stewart to advise the Canadian cannabis company in developing a new line of goods, including hemp-derived CBD products.
Walmart Canada removes Canopy Growth’s cannabis vaporizer from website
Walmart Canada removed a popular medical marijuana vaporizer from its online store last month and now says it has no immediate plans to sell cannabis-related products.
Wall Street bank: Fears on cannabis commoditization overdone
A New York-based investment bank initiated coverage of the cannabis industry Monday, another sign that Wall Street prudence is catching up to main street excitement over the burgeoning sector. The global marijuana industry has a “base-case conservative” forecast worth...













